MEK activation is associated with a molecular subgroup in high grade serous ovarian cancer

被引：0
|
作者：
McCabe, Nuala
Gourley, Charlie
McGavigan, Andrena
Michie, Caroline .
McGivern, Niamh
Churchman, Michael
O'Brien, Eamonn J.
Hill, Laura
Davison, Timothy S.
Williams, Alistair
McCluggage, Glenn
Keating, Karen E.
Harkin, Denis P.
Kennedy, Richard D.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-453
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
453
引用
收藏
页数：4
相关论文
共 50 条
  • [1] MOLECULAR AND FUNCTIONAL HETEROGENEITY OF CANCER ASSOCIATED FIBROBLASTS IN HIGH-GRADE SEROUS OVARIAN CANCER
    Hussain, Ali
    Voisin, Veronique
    Poon, Stephanie
    Meens, Jalna
    Dmytryshyn, Julia
    Paterson, Josh
    Bernardini, Marcus
    Bader, Gary
    Neel, Benjamin G.
    Ailles, Laurie E.
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 134 - 134
  • [2] Molecular subgroup of high-grade serous ovarian cancer (HGSOC) as a predictor of outcome following bevacizumab.
    Gourley, Charlie
    McCavigan, Andrena
    Perren, Timothy
    Paul, James
    Michie, Caroline Ogilvie
    Churchman, Michael
    Williams, Alistair
    McCluggage, W. Glenn
    Parmar, Mahesh
    Kaplan, Richard S.
    Hill, Laura A.
    Haifpenny, Iris A.
    O'Brien, Earnonn J.
    Raji, Olaide
    Deharo, Steve
    Davison, Timothy
    Johnston, Patrick
    Keating, Katherine E.
    Harkin, D. Paul
    Kennedy, Richard D.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] T-cell activation is associated with high-grade serous ovarian cancer survival
    Wang, Lei
    Sun, Wenjie
    Zhang, Guoan
    Huo, Jingrui
    Tian, Yi
    Zhang, Yan
    Yang, Xiaohui
    Liu, Yingfu
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2022, 48 (08) : 2189 - 2197
  • [4] Defining the Molecular Footsteps of High-Grade Serous Ovarian Cancer
    Nagendra, P.
    Lombard, J.
    Jamaluddin, F.
    Tanwar, P.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 26 - 26
  • [5] Treatment of Recurrent Low-grade Serous Ovarian Cancer With MEK Inhibitors
    Kulkarni, Anjali
    Cooke, Carly
    Fazelzad, Rouhi
    Fung-Kee-Fung, Michael
    May, Taymaa
    Zigras, Tiffany
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (01): : 11 - 16
  • [6] Identification of a Molecular Subtype of High Grade Serous Ovarian Cancer Representing MAPK Pathway Activation and Platinum Resistance
    Brown, C. A.
    McCabe, N.
    Gourley, C.
    McCavigan, A.
    Michle, C. O.
    El-Helai, A.
    Price, B.
    McGivern, N.
    Churchman, M.
    O'Brien, E. J.
    Hill, L.
    Davison, T. S.
    Williams, A.
    McCluggage, W. G.
    Keating, K. E.
    Harkin, D. P.
    Kennedy, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 1005 - 1005
  • [7] MEK inhibition for low-grade serous ovarian cancer: are we there yet?
    Scaranti, Mariana
    Mathias-Machado, Maria Cecilia
    Guo, Christina
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (01) : 155 - 156
  • [8] Molecular Subtypes of High-Grade Serous Ovarian Cancer: The Holy Grail?
    Waldron, Levi
    Riester, Markus
    Birrer, Michael
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (10):
  • [9] Deciphering the molecular basis of tumor immunogenicity in high grade serous ovarian cancer
    Berry, Laurel
    Pullikuth, Ashok
    Chou, Jeff
    Kelly, Michael
    Miller, Lance
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S113 - S113
  • [10] Efficient molecular subtype classification of high-grade serous ovarian cancer
    Leong, Huei San
    Galletta, Laura
    Etemadmoghadam, Dariush
    George, Joshy
    Koebel, Martin
    Ramus, Susan J.
    Bowtell, David
    JOURNAL OF PATHOLOGY, 2015, 236 (03): : 272 - 277
12345